VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas. Cancer. 2023 12 01; 129(23):3772-3782.
View in:
PubMed
subject areas
Adolescent
Adult
Bone Neoplasms
Child
Gene Fusion
Humans
Neoplasms
Oncogene Proteins, Fusion
Protein Kinase Inhibitors
Pyrazoles
Receptor, trkA
Sarcoma
Soft Tissue Neoplasms
Tropomyosin
authors with profiles
DAVID SANGHYUN HONG